Carlo Baldassarre Federici

Government, Health and Not for Profit


Pubblicazioni recenti

TARRICONE R., AMATUCCI F., ARMENI P., Banks H., BORSOI L., CALLEA G., CIANI O., COSTA F., FEDERICI C. B., TORBICA A., Marletta M. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies Health Policy, 27 Marzo, 2021
FEDERICI C. B., FORNARO G., Roehr C. C. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome European Journal of Hospital Pharmacy, 2021, pp.ejhpharm-2020-002465
Drummond M., FEDERICI C. B., Busink E., Apel C., Kendzia D., Brouwer W. Performance-based risk-sharing agreements in renal care: current experience and future prospects Expert Review Of Pharmacoeconomics & Outcomes Research, 5 Marzo, 2021, pp.1-13
Grigore B., CIANI O., Dams F., FEDERICI C. B., de Groot S., Möllenkamp M., Rabbe S., Shatrov K., Zemplenyi A., Taylor R. S. Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines Pharmacoeconomics, 2020, vol.38, no. 10, pp.1055-1070
Barchiesi M., Bulgheroni M., FEDERICI C. B., Casella F., Medico M. D., Torzillo D., POPESCU J. V., TARRICONE R., Cogliati C. Impact of point of care ultrasound on the number of diagnostic examinations in elderly patients admitted to an internal medicine ward European Journal of Internal Medicine, 2020, vol.79, pp.88-92
Pirc E., FEDERICI C. B., Bošnjak M., Peric B., Reberšek M., Pecchia L., Glumac N., Cemažar M., Snoj M., Serša G., Miklavcic D. Early Cost-effectiveness Analysis of Electrochemotherapy as a Prospect Treatment Modality for Skin Melanoma Clinical Therapeutics, 2020, vol.42, no. 8, pp.1535-1548.e2

Articoli correlati

I PRO: la sanità vista con gli occhi del paziente
Tempo richiesto 5 min